Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase II, single-arm, efficacy and safety study of poziotinib (NOV120101) in Korean patients with advanced or metastatic lung adenocarcinoma who have acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
- Authors
- Han, Ji-Youn; Lee, Jin Soo; Lee, Ki Hyeong; Kim, Sang-We; Min, Young Joo; Cho, Eun Kyung; Lee, Young Joo; Lee, Soo-Hyun; Kim, Hyae Young; Lee, Geon Kook; Nam, Byung-Ho; Han, Jong Hee; Kim, Jung Yong; Jung, Jina
- Issue Date
- 20-May-2015
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.33, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 33
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)